About Jason Hafler
Jason Hafler is a managing director at Sanofi Ventures, Sanofi’s corporate venture capital arm. He is also a Matchpoint Therapeutics director. Matchpoint develops small-molecule medicines for immune diseases. He joined Abcuro’s board in January 2021.
He began at Sanofi Ventures in 2014 and became managing director in November 2019. Before Sanofi, he was RaNA Therapeutics’ director of corporate development from 2012 to 2014. He was an Atlas Venture associate from 2010 to 2012 and a Flagship Ventures entrepreneurial fellow in 2010. Earlier, he advised Cambridge’s technology transfer office and worked at JSB Partners. He joined Icosavax’s board in August 2019. His departure was planned for just before Icosavax’s registration became effective. In July 2021, he also served on boards at Buckingham Browne and Nichols School, the Magdalene College Foundation and Beacon Hill Nursery School. He completed an honors bachelor’s degree at Bowdoin College and a doctorate at the University of Cambridge.
Experience
This experience comes from official bios, from Jason Hafler's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jason Hafler in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jason Hafler works with at each company, as listed on that company's latest Form D.






